CSL-400

N/A

Report date: 2026/05/12 09:17:33

Base Information

Drug NameCSL-400

Drug Alias Name(TIV) sa-mRNA Trivalent Influenza VaccineCSL-400

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesCsl Ltd

China Registration ClassN/A

Develop Information

Active CompaniesCsl Ltd

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A